Showing results (81-90 of 107) with videos related to
Sort By:
Pageof 11
Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.Plos One|January 14, 2021
The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine modelsArna Katewa, Eric Suto, Jessica Hui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancerKenneth R Hess, Keith Anderson, W Fraser Symmans, et al.JAMA|July 27, 2016
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical TrialPaul D Brown, Kurt Jaeckle, Karla V Ballman, et al.The Lancet. Oncology|March 3, 2007
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling studyYun Gong, Kai Yan, Feng Lin, et al.International Journal of Radiation Oncology, Biology, Physics|March 27, 2021
Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for GlioblastomaNadia Nicole Laack, Deanna Pafundi, S Keith Anderson, et al.Science Immunology|May 8, 2021
IL-1R1-dependent signaling coordinates epithelial regeneration in response to intestinal damageChristian B Cox, Elaine E Storm, Varun N Kapoor, et al.Journal of the National Cancer Institute|May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic VirotherapyCheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.BMC Medical Genomics|December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platformMonica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.The Lancet. Oncology|July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialPaul D Brown, Karla V Ballman, Jane H Cerhan, et al.Pageof 11